Home › Funds › North Growth Management Ltd. › WST

North Growth Management Ltd. position in WST

WEST PHARMACEUTICAL SVSC INC · Health Care

North Growth Management Ltd. reported holding 63,000 shares of WST (WEST PHARMACEUTICAL SVSC INC) in its Q3 2026 13F filing — a position valued at US$23.5M, representing 3.16% of its reported portfolio and ranking #11 among its reported holdings. North Growth Management Ltd. has disclosed WST holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)63.00K sh
Reported value held$23.50M
Portfolio Weight3.16%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How North Growth Management Ltd.'s WST position evolved

North Growth Management Ltd. first disclosed a stake in WST in Q3 2023 at 10,000 shares (US$3.6M). The position peaked in Q3 2026 at 63,000 shares, worth US$23.5M. Across 13 filings, North Growth Management Ltd. increased the stake 9 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 63,000 shares valued at US$23.5M — an increase of 1,000 shares quarter over quarter.. Notable position changes include a 33% increase in Q1 2024 (shares fell 17% over the following quarter), a 39% increase in Q1 2025 (shares fell 2% over the following quarter), a 59% increase in Q1 2026 (shares rose 43% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 10.00K $3.61M New
Q4 2023 12.00K $4.34M Add
Q1 2024 16.00K $6.19M Add
Q2 2024 16.00K $5.16M Hold
Q3 2024 19.00K $5.56M Add
Q4 2024 18.00K $5.96M Reduce
Q1 2025 25.00K $5.49M Add
Q2 2025 29.00K $6.36M Add
Q3 2025 34.00K $8.93M Add
Q4 2025 39.00K $10.81M Add
Q1 2026 62.00K $15.55M Add
Q2 2026 62.00K $22.43M Hold
Q3 2026 63.00K $23.50M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About WST and 13F data

WST (WEST PHARMACEUTICAL SVSC INC) is a Health Care company. 28 other funds we track also report a position in WST — the largest reported positions include Artisan Partners Limited Partnership (US$744.4M), GENERATION INVESTMENT MANAGEMENT LLP (US$728.2M), BROWN ADVISORY INC (US$386.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding WST

All WST fund holders →

FAQ

How long has North Growth Management Ltd. held WST?

North Growth Management Ltd. has disclosed WST holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is North Growth Management Ltd.'s current position in WST?

As of Q3 2026, North Growth Management Ltd. holds 63.00K shares of WST (WEST PHARMACEUTICAL SVSC INC), valued at $23.50M, representing 3.16% of its reported portfolio and ranking #11.

Has North Growth Management Ltd. been buying or selling WST?

In the latest 13F filing (Q3 2026), North Growth Management Ltd. increased its position in WST. The position peaked in Q3 2026 at 63.00K shares.

Which other funds hold WST?

Other major institutional holders of WST include Artisan Partners Limited Partnership, GENERATION INVESTMENT MANAGEMENT LLP, BROWN ADVISORY INC, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.